CDTX Chart
- 52-Week Range: $0.43 - $2.35
- Market Capitalization: $32.02M
- Short Percentage: 0%
- Target Price: $5.91
- Shares Outstanding: 69.05M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CDTX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Tentarix Biotherapeutics Announces the Strengthening of its Leadership and Advisory TeamsBusiness Wire | May 20th
- FDA Clears Cidara Therapeutics' Phase 1 Trial For Immunotherapeutic Antiviral For InfluenzaBenzinga | February 14th
- Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire | January 6th
- Cidara Therapeutics Stock Slides Despite Acing Rezafungin Trial In Fungal InfectionBenzinga | December 14th
- 3 Biotech Penny Stocks To Watch With The Stock Market Down TodayPennyStocks | December 3rd
- Cidara Therapeutics Named A San Diego Metro Area Top Workplace For The Fifth Consecutive YearGlobeNewsWire | November 22nd
- Cidara Provides Corporate Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire | November 10th
Company Info
Website: https://www.cidara.com
Address: 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 89
Address: 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 89
$CDTX coming now
$CDTX just go up
$CDTX called it
$CDTX ready to explode
$CDTX omg lol
$CDTX we had no volume for days before the last big rip
$CDTX somebody knows something
$CDTX has just been halted from trading.
$CDTX my put options are fine
$CDTX how long until we take off?